Solar-D Derma-Tech designs Vitamin D SPF Technology that allows the human body to naturally produce vitamin D without sacrificing the sun protection factor (SPF). It uses private label and licensing opportunities to offer their technology to enable other skincare brands to use the patented technology. Solar-D Derma-Tech has manufacturing capabilities in Australia and the US with distribution partners across the globe including Pharmaceuticals companies and cosmetic brands. Through their technology, Solar-D Derma-Tech seeks to overcome health risks from low Vitamin D and improve the health and immunity of its consumers.

Edwards + Co have provided advice to Nexdius and its subsidiaries for over 5 years on a variety of commercial and corporate matters related to their core business and capital raising, including:

• Preparing, negotiating and refining large territorial licensing agreements for distributors of the Solar-D products and intellectual property internationally, including in China, India, Japan and Europe;
• Advising on regulation of the Solar-D products and technology under applicable consumer protection and therapeutic goods laws in Australia and overseas;
• Advising on matters related to the suite of IP rights underlying the products, and reviewing and preparing a range of associated agreements with licensors;
• Capital raising matters for the investment of equity capital and the issue of shares and options;
• Advising on litigation including in the Federal Court of Australia, and other commercial disputes including in relation to product manufacturing and licensing;
• Advising on matters related to shareholder relations and governance;
• Advising on the protection of various forms of IP, including trade marks and patents, in various worldwide markets where the product is distributed, and associated cross-border considerations; and
• Advising on and drafting employment, consultancy agreements and other contracting arrangements, and providing day-to-day operational advice on business issues.